Management of high-risk myelodysplastic
β
Francesco D. Pisani; Angela Rainaldi
π
Article
π
2001
π
Elsevier Science
π
English
β 202 KB
The myelodysplastic syndromes (MDS) are a group of clonal disorders characterized by one or more cytopenias secondary to bone marrow dysfunction. The percentage of bone marrow blasts, the number of cytopenic cell lines and cytogenetics define more precisely clinical risk groups. In the high-risk MDS